Permanent Pediatric Research Laws Would Spur In-House Units – J&J Exec

Enacting a permanent authorization for federal pediatric research programs would encourage pharmaceutical companies to create dedicated pediatric research programs within their operations, a Johnson & Johnson executive suggested to the Senate Health, Labor and Pensions Committee March 27